drugset / Trial / NCT06013956

Personalized Real-Time DBS and PD Mechanisms

NCT06013956

Phase 4 Recruiting 25 enrolled David Escobar The Cleveland Clinic · collab
RandomizedCrossoverTriple-blindBasic science

Summary

A prospective cohort of patients scheduled to undergo deep brain stimulation (DBS) implantation surgery for the treatment of Parkinson's disease as per standard of care will be invited to participate in this study. This mechanistic study is aimed at better understanding the role of basal ganglia beta band (11-35 Hz) oscillations and resonance in the manifestation of Parkinson's disease (PD) motor signs using closed-loop electrical neurostimulation, levodopa medication, and computational modeling. The ultimate goal of this study is to inform the development of closed-loop neuromodulation technology that can be programmed and adjusted in real time based on patient-specific neural activity.

Timeline

Start
2023-08-29
Primary completion
2028-06-30
Completion
2028-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Levodopa Small molecule 100 mg
Background Carbidopa Unknown 25 mg

Indications